Patent ID: 8466273

Claim:
An siRNA of the BGT-1 gene consisting of the nucleotide (a), (b), or (c) below: (a) an nucleotide consisting of the nucleotide sequence 5′-CAACAAGAUGGAGUUUGUGCUGUCA-3′ (SEQ ID NO: 1); (b) an nucleotide of 25-40 nucleotides in length including the nucleotide sequence 5′-CAACAAGAUGGAGUUUGUGCUGUCA-3′ (SEQ ID NO: 1); or (c) an nucleotide capable of hybridizing an nucleotide consisting of a nucleotide sequence complementary to an nucleotide consisting of the nucleotide sequence of SEQ ID NO: 1 under stringent conditions and capable of inhibiting the replication of hepatitis C virus.